VIR-165
VIR-165 is a modified form of virus inhibitory peptide (VIRIP) that binds the fusion peptide of the gp41 subunit and prevents its insertion into the target membrane. VIRIP inhibits a wide variety of human immunodeficiency virus type 1 (HIV-1) strains.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 943790-62-3
- Formule: C109H156N22O25S2
- Masse moléculaire:2238.67
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Chemical Information
-
CAS No. 943790-62-3
-
Masse moléculaire 2238.67
-
Formule C109H156N22O25S2
-
Sequence
Leu-Glu-Ala-Ile-Pro-Cys-Ser-Ile-Pro-Pro-Cys-Phe-Ala-Phe-Asn-Lys-Pro-Phe-Val-Phe (Disulfide bridge: Cys6-Cys11)
-
Sequence Shortening
LEAIPCSIPPCFAFNKPFVF (Disulfide bridge: Cys6-Cys11)
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Münch J, et al. Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide. Cell. 2007 Apr 20;129(2):263-75. [Content Brief]
[2]. Eggink D, et al. HIV-1 Escape from a Peptidic Anchor Inhibitor through Stabilization of the Envelope Glycoprotein Spike. J Virol. 2016 Nov 14;90(23):10587-10599. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)